Kindstar Globalgene Technology, Inc. (HKG:9960)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.090
+0.040 (3.81%)
At close: Mar 27, 2026
Market Cap1.09B -18.3%
Revenue (ttm)1.04B +0.6%
Net Income-65.37M
EPS-0.07
Shares Out996.57M
PE Ration/a
Forward PEn/a
Dividend0.02 (2.18%)
Ex-Dividend DateJun 9, 2025
Volume30,500
Average Volume352,778
Open1.100
Previous Close1.050
Day's Range1.050 - 1.130
52-Week Range1.030 - 1.750
Beta0.70
RSI40.06
Earnings DateMar 27, 2026

About HKG:9960

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, m... [Read more]

Sector Healthcare
Founded 2003
Employees 3,162
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9960
Full Company Profile

Financial Performance

In 2025, HKG:9960's revenue was 933.57 million, an increase of 0.65% compared to the previous year's 927.57 million. Losses were -58.74 million, 7.61% more than in 2024.

Financial numbers in CNY Financial Statements